Navigation Links
Quorum IRB Board Chair to Speak at South Korean Research Summit
Date:9/17/2013

Seattle, WA (PRWEB) September 17, 2013

Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, will speak at the 2013 Global Clinical Research Summit to be held Oct. 1 and 2 in Daegu, South Korea. This year’s gathering will focus on the “Innovative, Integrative and Personalized Care Approach” in worldwide human subject research.

Dr. Rosenfeld’s discussion on Oct. 1 is entitled “CIM Challenge to Global Unique Model as Pioneer” and will cover how to perform rigorous research combining western therapeutic practice and traditional Korean medicine. This will mark the first time a member of the Quorum Review Board presents in Asia since the renowned IRB expanded its services to international markets outside of the U.S. and Canada.

As previously announced, Dr. Rosenfeld was recently appointed to the Secretary’s Advisory Committee on Human Research Protections (SACHRP), an exclusive panel that advises the U.S. Secretary of Health and Human Services in the area of human research subjects. His appearance at the summit is expected to combine the detailed approach he employs as Quorum Review’s Board Chair with that of his broader scope as a SACHRP member who is improving the research oversight process.

Rosenfeld says, “It's an honor to be representing Quorum Review IRB in South Korea at this prestigious event, and I am looking forward to contributing to the international perspective on human clinical research.”

For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review IRB

Quorum Review is an independent review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the United States and internationally, a specialized Phase I team, and unique processes for post-approval and registry studies.

Contact

Arri Burgess
Director, Client Relations & Marketing
Quorum Review IRB
(206) 436-3244
aburgess(at)quorumreview(dot)com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11115823.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. Quorum Review IRB and ConsentSolutions Form Strategic Alliance
3. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
4. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
5. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
6. GenturaDx Announces Formation of Scientific Advisory Board
7. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
8. DiaTech Life Sciences Announces Medical Advisory Board
9. BioStorage Technologies Appoints New Member to Board of Directors
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... is now being assessed in clinical trials in the United States. (clinicaltrials.gov : ... your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ ...
(Date:9/21/2017)... , ... September 21, 2017 , ... Dr. Greg Leyer, ... Vegas, NV on September 27th. His presentation is at 12:10pm in the Probiotics Resource ... to present at SupplySide West and discuss how probiotics have shown impressive data in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Colpitts Clinical has launched the ... includes new features that facilitate streamlined and compliant communication, file sharing and document ... forefront of medical advancements, they rely on efficiencies to help them address the ...
(Date:9/21/2017)... New Jersey (PRWEB) , ... September 21, 2017 ... ... highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 ... Part 11 training - Compliance with Regulation 21 CFR Part 11 on ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):